Cargando…

Epigenetic Regulation of m(6)A Modifications in Human Cancer

N6-methyladenosine (m(6)A) is the most prevalent internal RNA modification, especially within eukaryotic messenger RNAs (mRNAs). m(6)A modifications of RNA regulate splicing, translocation, stability, and translation into proteins. m(6)A modifications are catalyzed by RNA methyltransferases, such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wei, Qi, Xiaoqian, Liu, Lina, Liu, Zihao, Ma, Shiqing, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938965/ https://www.ncbi.nlm.nih.gov/pubmed/31887551 http://dx.doi.org/10.1016/j.omtn.2019.11.022

Ejemplares similares

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m(6)A Modification
por: Zhao, Wei, et al.
Publicado: (2020)

Emerging Epigenetic Regulation of Circular RNAs in Human Cancer
por: Wu, Jie, et al.
Publicado: (2019)

Epigenetic modification of m(6)A regulator proteins in cancer
por: Wang, Yumin, et al.
Publicado: (2023)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

METTL3-mediated m(6)A modification regulates cell cycle progression of dental pulp stem cells
por: Luo, Haiyun, et al.
Publicado: (2021)

N(6)-methyl-adenosine (m(6)A) in RNA: An Old Modification with A Novel Epigenetic Function
por: Niu, Yamei, et al.
Publicado: (2013)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
por: Yu, Xilan, et al.
Publicado: (2018)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
por: Tong, Huan, et al.
Publicado: (2022)

Aberrant Regulation of mRNA m(6)A Modification in Cancer Development
por: Luo, Junyun, et al.
Publicado: (2018)

The potential roles of m(6)A modification in regulating the inflammatory response in microglia
por: Li, Qi, et al.
Publicado: (2021)

Long-term exercise training down-regulates m(6)A RNA demethylase FTO expression in the hippocampus and hypothalamus: an effective intervention for epigenetic modification
por: Liu, Shu-Jing, et al.
Publicado: (2022)

Dynamic regulation and functions of mRNA m6A modification
por: Wang, Shanshan, et al.
Publicado: (2022)

The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer
por: Zhu, Wenjing, et al.
Publicado: (2022)

Identification of m(6)A Regulator-Associated Methylation Modification Clusters and Immune Profiles in Melanoma
por: Du, Fengying, et al.
Publicado: (2021)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Intertwined regulation between RNA m(6)A modification and cancer metabolism
por: Liu, Jiaxu, et al.
Publicado: (2022)

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer
por: Ren, Shuwei, et al.
Publicado: (2023)

The roles of epigenetic modifications in the regulation of auxin biosynthesis
por: Wang, Jun-Li, et al.
Publicado: (2022)

METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021)

Epigenetic modifications of histones in cancer
por: Zhao, Zibo, et al.
Publicado: (2019)

Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
por: Liu, Jie, et al.
Publicado: (2023)

m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
por: Yue, Shi-Wei, et al.
Publicado: (2023)

Epigenetic modifications in esophageal cancer: An evolving biomarker
por: Liu, Wen-Jian, et al.
Publicado: (2023)

Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
por: Saggese, Pasquale, et al.
Publicado: (2020)

Link Between m6A Modification and Cancers
por: Liu, Zhen-Xian, et al.
Publicado: (2018)

Epigenetic modification in Parkinson’s disease
por: Song, Hao, et al.
Publicado: (2023)

Editorial: Epigenetic regulation and non-histone post-translational modification in cancer
por: Luo, Jiang, et al.
Publicado: (2023)

Fear Stress During Pregnancy Affects Placental m6A-Modifying Enzyme Expression and Epigenetic Modification Levels
por: Wang, Qiyang, et al.
Publicado: (2022)

Epigenetic Regulation and Post-Translational Modifications of SNAI1 in Cancer Metastasis
por: Dong, Bo, et al.
Publicado: (2021)

HSPC117 Is Regulated by Epigenetic Modification and Is Involved in the Migration of JEG-3 Cells
por: Ma, Hong, et al.
Publicado: (2014)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

Identification and experimental validation of key m6A modification regulators as potential biomarkers of osteoporosis
por: Qiao, Yanchun, et al.
Publicado: (2023)

The CTBP2-PCIF1 complex regulates m(6)Am modification of mRNA in head and neck squamous cell carcinoma
por: Li, Kang, et al.
Publicado: (2023)

Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
por: Catalano, Maria Graziella, et al.
Publicado: (2012)

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology
por: Sacco, Antonio, et al.
Publicado: (2010)

LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications
por: Huang, Shiqing, et al.
Publicado: (2022)

Epigenetic m6A RNA Modification Reader YTHDF1 in Merkel Cell Carcinoma
por: Jaguri, Aayami, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_23mmbdds4shtp7ul7p8t7716hk